Gwen Buel

Gwen is a technology specialist supporting the Intellectual Property practice and the Life Sciences industry team. Her focus is on patent prosecution and intellectual property matters involving biotechnology, biochemistry, and the life sciences. She assists biotechnology companies and other innovators in protecting scientific discoveries and advancing their intellectual property strategies.

Gwen assists with drafting and prosecuting U.S. and international patent applications, conducting patentability and freedom-to-operate analyses, and performing intellectual property due diligence. Her technical background encompasses molecular biology, protein biochemistry, structural biology, and cell signaling, with particular experience in protein-protein interactions and nuclear magnetic resonance (“NMR”) spectroscopy for protein structure determination.

Prior to joining AGG, Gwen was a senior scientist at a biotechnology company, where she developed a novel purification methodology for Anellovirus capsid proteins and optimized methods for encapsidating single-stranded DNA payloads. She also conducted postdoctoral research at the National Cancer Institute, part of the National Institutes of Health (“NIH”), where she investigated protein structures and interactions using advanced analytical techniques and computational tools, including AlphaFold. Her research resulted in publications in Nature Communications, Nature Structural & Molecular Biology, and Structure.

Gwen earned her Ph.D. in biological and biomedical sciences from Harvard University, where her research focused on amino acid regulation of mTORC1 signaling. Her scientific accomplishments have been recognized through competitive NIH research awards and fellowships, including the CCR Excellence in Postdoctoral Research Transition Award and the Sallie Rosen Kaplan Postdoctoral Fellowship for Women Scientists.

Drawing on her experience in both academic and commercial research environments, Gwen understands the scientific challenges involved in translating discoveries into practical applications. She brings a detail-oriented, analytical perspective to IP matters, helping bridge the gap between sophisticated scientific concepts and patent protection objectives tailored to clients’ innovations.